Guardion Health Sciences, Inc. (GHSI)
USD 3.22
(0.0%)
USD 3.22
(0.0%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | 2.67 Million USD | -14.18% |
| 2022 | 3.11 Million USD | 748.38% |
| 2021 | 367.69 Thousand USD | -4.49% |
| 2020 | 384.97 Thousand USD | 23.81% |
| 2019 | 310.94 Thousand USD | -13.14% |
| 2018 | 357.99 Thousand USD | 131.37% |
| 2017 | 154.73 Thousand USD | 251.67% |
| 2016 | 43.99 Thousand USD | 43.96% |
| 2015 | 30.56 Thousand USD | 26.15% |
| 2014 | 24.22 Thousand USD | -74.16% |
| 2013 | 93.76 Thousand USD | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q1 | 2.13 Million USD | -20.28% |
| 2024 Q2 | 77.79 Thousand USD | -96.35% |
| 2023 Q4 | 2.67 Million USD | 9.24% |
| 2023 Q2 | 2.51 Million USD | -17.9% |
| 2023 FY | 2.67 Million USD | -14.18% |
| 2023 Q3 | 2.45 Million USD | -2.48% |
| 2023 Q1 | 3.06 Million USD | -1.88% |
| 2022 Q2 | 1.7 Million USD | 107.89% |
| 2022 Q1 | 822.32 Thousand USD | 123.65% |
| 2022 FY | 3.11 Million USD | 748.38% |
| 2022 Q4 | 3.11 Million USD | 59.73% |
| 2022 Q3 | 1.95 Million USD | 14.24% |
| 2021 Q2 | 956.25 Thousand USD | 231.43% |
| 2021 Q3 | 792.63 Thousand USD | -17.11% |
| 2021 Q4 | 367.69 Thousand USD | -53.61% |
| 2021 Q1 | 288.52 Thousand USD | -25.05% |
| 2021 FY | 367.69 Thousand USD | -4.49% |
| 2020 Q2 | 1.23 Million USD | 62.7% |
| 2020 Q3 | 1.28 Million USD | 3.98% |
| 2020 Q4 | 384.97 Thousand USD | -70.02% |
| 2020 Q1 | 759.08 Thousand USD | 144.13% |
| 2020 FY | 384.97 Thousand USD | 23.81% |
| 2019 Q3 | 320.35 Thousand USD | 0.52% |
| 2019 FY | 310.94 Thousand USD | -13.14% |
| 2019 Q4 | 310.94 Thousand USD | -2.94% |
| 2019 Q2 | 318.68 Thousand USD | 4.89% |
| 2019 Q1 | 303.81 Thousand USD | -15.13% |
| 2018 Q3 | 381.26 Thousand USD | -7.54% |
| 2018 Q4 | 357.99 Thousand USD | -6.1% |
| 2018 FY | 357.99 Thousand USD | 131.37% |
| 2018 Q1 | 182.91 Thousand USD | 18.22% |
| 2018 Q2 | 412.35 Thousand USD | 125.43% |
| 2017 Q2 | 108.3 Thousand USD | 116.5% |
| 2017 Q1 | 50.02 Thousand USD | 13.69% |
| 2017 FY | 154.73 Thousand USD | 251.67% |
| 2017 Q4 | 154.73 Thousand USD | -13.09% |
| 2017 Q3 | 178.03 Thousand USD | 64.38% |
| 2016 Q1 | - USD | -100.0% |
| 2016 FY | 43.99 Thousand USD | 43.96% |
| 2016 Q4 | 43.99 Thousand USD | -33.21% |
| 2016 Q3 | 65.87 Thousand USD | 94.57% |
| 2016 Q2 | 33.85 Thousand USD | 0.0% |
| 2015 Q1 | - USD | -100.0% |
| 2015 Q4 | 30.56 Thousand USD | -20.28% |
| 2015 Q3 | 38.33 Thousand USD | 0.0% |
| 2015 FY | 30.56 Thousand USD | 26.15% |
| 2014 FY | 24.22 Thousand USD | -74.16% |
| 2014 Q4 | 24.22 Thousand USD | 0.0% |
| 2013 FY | 93.76 Thousand USD | 0.0% |
| Name | Inventory | Inventory Difference |
|---|---|---|
| Bright Green Corporation | - USD | -Infinity% |
| BioQuest Corp. | - USD | -Infinity% |
| Clever Leaves Holdings Inc. | 4.48 Million USD | 40.283% |
| Eagle Pharmaceuticals, Inc. | 47.79 Million USD | 94.399% |
| GSRX Industries Inc. | - USD | -Infinity% |
| High Sierra Technologies, Inc. | - USD | -Infinity% |
| Instadose Pharma Corp. | - USD | -Infinity% |